Dolby Laboratories (DLB): Price and Financial Metrics
Dolby Laboratories (DLB)
Today's Latest Price: $66.13 USD
Updated Jul 1 6:30pm
Add DLB to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 35 in Technology - Electronics
See all "A" rated Strong Buy stocks
DLB Stock Summary
- The ratio of debt to operating expenses for Dolby Laboratories Inc is higher than it is for about merely 12.66% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.23 for Dolby Laboratories Inc; that's greater than it is for merely 13.58% of US stocks.
- In terms of volatility of its share price, DLB is more volatile than only 7.56% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Dolby Laboratories Inc, a group of peers worth examining would be CGNX, TRIP, FFIV, DIOD, and AZPN.
- Visit DLB's SEC page to see the company's official filings. To visit the company's web site, go to www.dolby.com.
DLB Stock Price Chart Technical Analysis Charts
DLB Price/Volume Stats
| Current price | $66.13 | 52-week high | $73.20 |
| Prev. close | $65.87 | 52-week low | $44.68 |
| Day low | $65.00 | Volume | 456,398 |
| Day high | $66.67 | Avg. volume | 471,885 |
| 50-day MA | $61.16 | Dividend yield | 1.33% |
| 200-day MA | $63.84 | Market Cap | 6.66B |
Dolby Laboratories (DLB) Company Bio
Dolby Laboratories creates audio, imaging, and communication technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company was founded in 1965 and is based in San Francisco, California.
DLB Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $66.13 | $16.6 | -75% |
Below please find a table outlining a discounted cash flow forecast for DLB, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Dolby Laboratories Inc ranked in the 19th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Dolby Laboratories Inc, consider:
- Interest coverage, a measure of earnings relative to interest payments, is 1,386.2 -- which is good for besting 99.17% of its peer stocks (US stocks in the Consumer Cyclical sector with positive cash flow).
- The business' balance sheet reveals debt to be 1% of the company's capital (with equity being the remaining amount). Approximately merely 5.91% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
- DLB's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 54.89% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -75% |
| 1% | -75% |
| 2% | -75% |
| 3% | -75% |
| 4% | -74% |
| 5% | -74% |
Want more companies with a valuation profile/forecast similar to that of Dolby Laboratories Inc? See CRMT, BBBY, LUVU, SALM, and CLAR.
Loading social stream, please wait...